Global epidemiology of meningococcal disease

This publication has 167 references indexed in Scilit:

• Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086
  Journal of Biological Chemistry, 2009
• A generic mechanism inNeisseria meningitidisfor enhanced resistance against bactericidal antibodies
  The Journal of Experimental Medicine, 2008
• Emergence of Endemic Serogroup W135 Meningococcal Disease Associated with a High Mortality Rate in South Africa
  Clinical Infectious Diseases, 2008
• Genetic and Antigenic Analysis of Invasive Serogroup Y Neisseria meningitidis Isolates Collected from 1999 to 2003 in Canada
  Journal of Clinical Microbiology, 2007
• Prevalence of Factor H–Binding Protein Variants and NadA among Meningococcal Group B Isolates from the United States: Implications for the Development of a Multicomponent Group B Vaccine
  The Journal of Infectious Diseases, 2007
• Clonal Distribution of Invasive Neisseria meningitidis Serogroup C Strains Circulating from 1976 to 2005 in Greater São Paulo, Brazil
  Journal of Clinical Microbiology, 2007
• No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales
  The Lancet Infectious Diseases, 2006
• Invasive Meningococcal Disease in Québec, Canada, Due to an Emerging Clone of ST-269 Serogroup B Meningococci with Serotype Antigen 17 and Serosubtype Antigen P1.19 (B:17:P1.19)
  Journal of Clinical Microbiology, 2006
• A universal vaccine for serogroup B meningococcus
  Proceedings of the National Academy of Sciences, 2006
• Meningococcal Disease in Los Angeles County, California, and among Men in the County Jails
  New England Journal of Medicine, 1996